31 related articles for article (PubMed ID: 20352612)
1. An Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS) Method for Qualifying DAPB in Rat Plasma and Application to Pharmacokinetic Studies.
Qin B; Chen Y; Yang K; Wang R; Yu L; Wang N; Liu S
Molecules; 2024 Jan; 29(2):. PubMed ID: 38276619
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a sensitive, fast and simple LC-MS / MS method for the quantitation of favipiravir in human serum.
Eryavuz Onmaz D; Abusoglu S; Onmaz M; Yerlikaya FH; Unlu A
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1176():122768. PubMed ID: 34052564
[TBL] [Abstract][Full Text] [Related]
3. Rat Pharmacokinetics and In Vitro Metabolite Identification of KM-819, a Parkinson's Disease Candidate, Using LC-MS/MS and LC-HRMS.
Choi HI; Kim T; Kim JW; Lee GJ; Choi J; Chae YJ; Kim E; Koo TS
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474516
[TBL] [Abstract][Full Text] [Related]
4. Rapid and simultaneous quantification of levetiracetam and its carboxylic metabolite in human plasma by liquid chromatography tandem mass spectrometry.
Yeap LL; Lo YL
PLoS One; 2014; 9(11):e111544. PubMed ID: 25375249
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a chiral UPLC-MS/MS method for quantifying S-Oxiracetam and R-Oxiracetam in human plasma, urine and feces: Application to a phase-I clinical pharmacokinetic study.
Wang Y; Liu Y; Sha Y; Li J; Han L; Chen H; Su S; Li N; Chen X; Zhao D
J Pharm Biomed Anal; 2024 Feb; 239():115881. PubMed ID: 38101242
[TBL] [Abstract][Full Text] [Related]
6. Supported liquid extraction combined with liquid chromatography tandem mass spectrometry for the quantitative analysis of a TLR7 agonist imiquimod LFX453 in plasma at low picograms per milliliter: Method validation and its application to a pharmacokinetic study in minipig.
Heudi O; Winter S
Biomed Chromatogr; 2024 Jan; 38(1):e5769. PubMed ID: 37937618
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an LC-MS/MS method for quantification of lifitegrast in rabbit plasma and ocular tissues and its application to pharmacokinetic study.
Kim E; Jang E; Jung W; Kim W; Lee J; Choi DH; Shin BS; Shin S; Kim TH
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123892. PubMed ID: 37788538
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of the ataxia-telangiectasia-mutated and Rad3-related inhibitor elimusertib (BAY-1895344) in human plasma using LC-MS/MS.
Kiesel BF; Parise RA; Krishnamurthy A; Gore S; Beumer JH
Biomed Chromatogr; 2022 Nov; 36(11):e5455. PubMed ID: 35876841
[TBL] [Abstract][Full Text] [Related]
9. Validation of a universal and highly sensitive two-dimensional liquid chromatography-tandem mass spectrometry methodology for the quantification of pyrazinamide, ethambutol, protionamide, and clofazimine in different biological matrices.
Wu S; Fan X; Jiang J; Ho CM; Ding X; Lou Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1151():122141. PubMed ID: 32526663
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of LC-MS/MS method for estimating the pharmacokinetics, protein binding, and metabolic stability of soluble epoxide hydrolase inhibitor EC5026.
Biradar R; Dey S; Mane SS; Dengale SJ
J Pharm Biomed Anal; 2024 Jan; 237():115797. PubMed ID: 37847987
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of piracetam and its four impurities by RP-HPLC with UV detection.
Arayne MS; Sultana N; Siddiqui FA; Mirza AZ; Qureshi F; Zuberi MH
J Chromatogr Sci; 2010 Aug; 48(7):589-94. PubMed ID: 20819285
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic Study of Piracetam in Focal Cerebral Ischemic Rats.
Paliwal P; Dash D; Krishnamurthy S
Eur J Drug Metab Pharmacokinet; 2018 Apr; 43(2):205-213. PubMed ID: 28916907
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Neuroplasticity by the Metabolic Enhancer Piracetam Associated with Improved Mitochondrial Dynamics and Altered Permeability Transition Pore Function.
Stockburger C; Miano D; Pallas T; Friedland K; Müller WE
Neural Plast; 2016; 2016():8075903. PubMed ID: 27747106
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products.
El-Houssini OM; Zawilla NH; Mohammad MA
Anal Chem Insights; 2013; 8():99-106. PubMed ID: 24137049
[TBL] [Abstract][Full Text] [Related]
15. Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam.
Leuner K; Kurz C; Guidetti G; Orgogozo JM; Müller WE
Front Neurosci; 2010; 4():. PubMed ID: 20877425
[TBL] [Abstract][Full Text] [Related]
16. Determination of piracetam in rat plasma by LC-MS/MS and its application to pharmacokinetics.
Wang X; Zhu J; Xu R; Yang X; Wu H; Lin D; Ye F; Hu L
Biomed Chromatogr; 2010 Oct; 24(10):1108-12. PubMed ID: 20352612
[TBL] [Abstract][Full Text] [Related]
17. Determination of pethidine in human plasma by LC-MS/MS.
Wang X; Xiang Z; Cai X; Wu H; Wang X; Li J; Zhang M
Biomed Chromatogr; 2011 Jul; 25(7):833-7. PubMed ID: 20872940
[TBL] [Abstract][Full Text] [Related]
18. A rapid and sensitive liquid chromatography-tandem mass spectrometric method for the determination of timosaponin B-II in blood plasma and a study of the pharmacokinetics of saponin in the rat.
Cai F; Sun L; Gao S; Yang Y; Yang Q; Chen W
J Pharm Biomed Anal; 2008 Dec; 48(5):1411-6. PubMed ID: 19027255
[TBL] [Abstract][Full Text] [Related]
19. Determination of caudatin-2,6-dideoxy-3-O-methy-beta-d-cymaropyranoside in rat plasma using liquid chromatography-tandem mass spectrometry.
Peng Y; Li Y; Wang D; Liu X; Zhang J; Qian S; Duan J
Biomed Chromatogr; 2008 Jun; 22(6):575-80. PubMed ID: 18189267
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
